Viracta (VIRX) Sotuvning operatsion marjasi

Ommaviy kompaniya Viracta Therapeutics (VIRX) logotipi

Viracta Therapeutics (VIRX) o'zining maqsadli terapiyalari uchun klinik sinovlar natijalarini kutayotgan bir paytda yetarli likvidlik zaxirasiga tayanadi. Operatsion marjaning tebranishlari takrorlanuvchi daromadning yo'qligini aks ettiradi, chunki biznes tadqiqot va ishlanmalar bosqichida qolmoqda. Loyihaning muvaffaqiyati EBV-o'simta terapiyasining samaradorligiga va limfoma bemorlarining javobiga bog'liq. Joriy 0.00 ko'rsatkichi moliyaviy barqarorlikning ushbu darajasini belgilaydi.

VIRX: Viracta Therapeutics Operatsion marja 04.07.2022 - 16.02.2025

Viracta Therapeutics Inc. (VIRX) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental baholanishi:Viracta Therapeutics, VIRX
Viracta Therapeutics, Inc. brendining mahsuloti

Viracta Therapeutics (VIRX) xalqaro klinik sinovlar logistikasining samaradorligi uning asosiy operatsion rentabelligi dinamikasida aks etgan. Ushbu ko'rsatkich foizlar va soliqlar to'lanishidan oldingi operatsion foydaning umumiy daromadga nisbatiga asoslanib hisoblanadi, bu esa kapital tuzilmasi va soliq yuklarining ta'sirini istisno qilgan holda, kompaniyaning biologik preparatlardan pul oqimini yaratish qobiliyatini baholash imkonini beradi.

Viracta Therapeutics raqobatchilari

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|Sotuvning operatsion marjasi Accuray, Inc. ARAY|Operatsion rentabellik sellaslifesciences.com SLS|Operatsion foyda normasi ACTU|CTOR - Operatsion rentabellik|Operatsion faoliyat rentabelligi tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operatsion rentabellik|FATE: Operatsion foyda koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Operatsion marja|TCRX (TScan Therapeutics) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Champions Oncology (CSBR)|Operatsion faoliyat rentabelligi XBiotech USA|Operatsion rentabellik CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Sotuvning operatsion rentabelligi|RADX - Operatsion rentabellik|ARTV - Operatsion marja|Adlai Nortye Ltd (ANL) - Operatsion rentabellik|Veru Pharma - Operatsion foyda normasi|Operatsion rentabellik Tempest Therapeutics Corp|Operatsion foyda bo'yicha sotuv rentabelligi XLO (Xilio Therapeutics, Inc.)|Operatsion marja RENB|MURA (Mural Oncology) - Operatsion foyda normasi|Operatsion marja KAPA (Kairos Pharma Ltd)|OKUR: Operatsion foyda bo'yicha sotuv rentabelligi|GDTC: Sotuvning operatsion marjasi|CRIS - Operatsion marja|APLM: Operatsion marja|Sotuvning operatsion rentabelligi tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Operatsion marja|Operatsion marja Genprex Inc.|Operatsion marja CLDI|Sotuvning operatsion marjasi Sunshine Biopharma, Inc. SBFM|Operatsion marja XBIO (Xenetic Biosciences)|Operatsion foyda normasi SLRX|PPBT - Operatsion rentabellik|AONC (aoncology.com) - Operatsion foyda bo'yicha sotuv rentabelligi|BGNE: Operatsion marja|Checkpoint Therapeutics Inc (CKPT) - Operatsion marja|ELEV (Elevation Oncology Inc.) - Operatsion marja|icadmed.com (ICAD) - Operatsion faoliyat rentabelligi|Operatsion marja IKNA|NTBL (Notable Labs) - Operatsion foyda normasi|Operatsion rentabellik MorphoSys Corporation MOR|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja